(2021) found that, in long-term gastric adenocarcinoma survivors, this pathway was still enriched with other-immune-related pathways (i.e., IL-17 signaling, complement cascade, IFNα/γ signaling), suggesting a positive role in tumor immunity (44). This evidence concerns the gene IL17A and neoplasm.